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Abstract:  The three main cannabinoids Δ9-tetrahydrocannabinol (Δ9-THC), 
cannabidiol (CBD) and cannabinol (CBN) were identified and determined 
quantitatively using a GCD (GC-EI) instrument in 280 samples of illicit herbal 
cannabis, seized by the Police authorities in Novi Sad, during 2008. The sam-
ples were sent to the Institute of Forensic Medicine, Clinical Center Vojvodina, 
for forensic chemical analysis. The cannabinoid content of the samples enabled 
the classification of the cannabis into three chemical phenotypes and the diffe-
rentiation into drug and textile-cannabis, using the Waller classification index. 
This differentiation has great forensic significance in the classification of cer-
tain cases as a criminal action. The experimental results showed that the Δ9-THC 
content in illicitly circulated cannabis slightly decreased from January to De-
cember 2008, as did the quality of the drug-cannabis. The reasons for the qua-
lity variations could lie in the geographical origin of the cannabis plants, the 
conditions of plants storage, various parts of the plants in samples and the time 
elapsed between harvesting and chemical analysis. 
Keywords: cannabinoids; forensic samples; GCD analysis; phenotype; Waller 
index. 
INTRODUCTION 
Cannabis (Cannabis sativa L.) is a plant widely distributed throughout the 
world and its cultivation is prohibited in most countries, including Serbia. The 
fibre-type plants are legally cultivated in some regions under specific permission. 
The three main cannabinoids found in Cannabis sativa L. are the psycho-
active Δ9-tetrahydrocannabinol (Δ9-THC) and the non-psychoactive cannabidiol 
(CBD) and cannabinol (CBN). The highest cannabinoid content is found in the 
resin secreted by the flowering buds of the plants. Δ9-THC, which is the main 
psychoactive constituent, is found in similar amounts in male and female canna-
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bis grown under the same conditions. It was shown that in the various parts of 
cannabis plant, the Δ9-THC content decreases in the following order: bracts, flo-
wers, smaller stems, larger stems, roots and seeds.1 
Textile (fibre-type) cannabis is cultivated for a wide variety of hemp-based 
products, such as: edible seed oil, essential oils, flour, beverages (beer, lemonade 
and liqueur), cosmetics, lubricants, fuels and fibres for the paper and building in-
dustries.1,2 Resinous (drug-type) cannabis is illicitly cultivated for its psychoac-
tive pharmacological action.3 
Since cannabis is most commonly administered by smoking or ingesting, the 
THC predominantly acts on the central nervous (CNS) and cardiovascular sys-
tems. Common CNS effects include euphoria, a sense of well-being, relaxation, 
tachycardia, alteration in blood pressure and hallucinations at high doses.4,5 
For court testimonies and police authority purposes, seized cannabis sam-
ples, after chemical analysis, are classified into three chemical phenotypes: drug, 
intermediate and fibre-type, according to the Δ9-THC content and the Waller 
classification index, W, (Eq. (1)):6,7 
 
9 % -THC+% CBN  Δ
% CBD
W =  (1) 
1. % Δ9-THC > 0.3 and W > 1; the plant is classified as a drug-type (resinous 
cannabis) and could be abused as a psychoactive drug; 
2. a) % Δ9-THC < 0.3 and W > 1 or b) % Δ9-THC > 0.3 and W < 1; the plant 
is classified as an intermediate-type and could be abused as a psychoactive drug; 
3. % Δ9-THC < 0.3 and W < 1; the plant is classified as a fibre-type (textile 
cannabis) and could not be abused. 
It is necessary to emphasize that a low content of Δ9-THC (% Δ9-THC < 
< 0.3) in intermediate-type cannabis samples is not incompatible with their re-
sinous character. As it is known that in these samples CBN, a degradation pro-
duct of Δ9-THC, is present in a large amounts, the % Δ9-THC + % CBN would 
approximate the Δ9-THC content. When the Waller classification index is low (W 
< 1) in intermediate-type cannabis samples, the CBD content is high, which 
indicates that the samples originated from relatively young potent plant.6 
According to the law in European Union countries, the maximum permitted 
content of Δ9-THC in fibre-type cannabis varieties is 0.3 %.8,9 Based on the Δ9- 
-THC content and the Waller classification index, forensic cannabis samples are 
differentiated into drug cannabis, if they are drug or intermediate-type, and tex-
tile cannabis, if they are fibre-type. This differentiation has great forensic signifi-
cance in the classification of certain cases as a criminal action. 
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EXPERIMENTAL 
Sample preparation 
Two hundred and eighty illicit herbal cannabis samples, seized by Police authorities in 
Novi Sad during 2008, were sent to the Institute of Forensic Medicine, Clinical Center Voj-
vodina, for forensic chemical analysis. The stems and seeds were manually separated from the 
dried plant material, leaving leaves, blossoms, small structural parts of the inflorescence and 
bracts. The resulting material was weighed and ground in a mortar. Each sample consisting of 
50 mg ground powder was heated with 5 ml petroleum ether (boiling range 40–60 °C) at 60 
°C for 20 min.10,11 After cooling, the petroleum ether extract was filtered and evaporated to 
dryness. The residue was reconstituted in 1.9 ml petroleum ether, 0.1 ml of epi-androsterone 
as the internal standard (IS) was added at a concentration 7 mg ml-1 in ethanol,7 and a 1-µl 
aliquot of the resulting solution was injected into the GCD instrument. 
Gas chromatographic analysis 
The cannabinoid content (% Δ9-THC, % CBD and % CBN) was determined chromato-
graphically using a G 1800 A GCD instrument, equipped with an HP 6890 autosampler. GCD 
is an advanced gas chromatography (GC) system introduced by Hewlett Packard in 1994. The 
GCD consists of a chromatograph, electron ionization (EI) detection system for m/z up to 425 
and a data acquisition system. The EI detection system generates retention time, abundance 
and mass spectral data that are comparable with those obtained with a GC–mass spectrometry 
(MS) instrument. 
The conditions for the analysis were as follows: column HP-5MS (30 m×0.25 mm i. d., 
film thickness 0.25 µm); injection port temperature: 250 °C; interface temperature: 280 °C; 
split mode: 1:11; oven temperature: initial, 50 °C; initial time: 0 min; heating rate: 25 °C min-1, 
final temperature: 250 °C, final time: 10 min; helium flow rate: 1 ml min-1. 
Standard solutions 
Stock standard solutions containing Δ9-THC, CBD and CBN at 1 mg ml-1 concentration 
in methanol, purchased from Sigma–Aldrich, Germany, were diluted with petrol ether and 
calibration standards were prepared at the concentrations: 500, 250, 100 and 50 μg ml-1, 
containing epi-androsterone (IS) at a concentration 350 μg ml-1. 
RESULTS AND DISCUSSION 
The major constituents of the seized cannabis samples were identified and 
quantitatively determined using a GCD instrument. The retention times of Δ9-THC, 
CBD, CBN and epi-androsterone were 14.44, 12.99, 15.70 and 15.22 min, res-
pectively. For quantitative analysis, the chosen characteristic mass fragments were 
monitored in the SCAN mode: m/z 314, 299 and 231 for Δ9-THC, m/z 231, 174 
and 314 for CBD, m/z 295, 238 and 310 for CBN, and m/z 290, 246 and 107 for 
epi-androsterone. 
The cannabinoid content of the cannabis samples led to the differentiation of 
the cannabis into drug, intermediate and fibre-type, then into drug and textile 
cannabis, according to the Waller classification index. 
Typical total ion chromatograms (TIC) of drug, intermediate and fibre-type 
cannabis samples are presented in Figs. 1–3, respectively. 
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Fig. 1. TIC gas chromatogram of a drug-type cannabis sample. 
 
Fig. 2. TIC gas chromatogram of an intermediate-type cannabis sample. 
 
Fig. 3. TIC gas chromatogram of a fibre-type cannabis sample. 
The percentage of Δ9-THC and the Waller classification index of the 280 
cannabis samples seized during 2008 are presented in Table I. 
The percent of drug, intermediate and fibre-type cannabis during 2008 is 
presented in Fig. 4 and the percent of cannabis samples classified as a drug or 
textile during 2008 is presented in Fig. 5. 
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TABLE I. % Δ
9-THC and Waller classification index of 280 cannabis samples during 2008 
Sample Month %  THC 
W 
index 
Sample Month %  THC
W 
index
Sample Month %  THC 
W 
index 
1 January 3.001  3.69 95  June  0.158 1.48  189 October 2.126 6.38 
2   2.143  1.75  96   3.670  10.15 190    0.059  0.03 
3   3.433  7.11  97   0.910  8.56  191    0.037  0.02 
4   4.633  5.23  98   3.520  7.32  192    0.507  8.36 
5   4.262  4.25  99   0.366  7.63  193    1.124  4.62 
6   0.570  8.03  100    1.207  13.03 194    0.643  1.06 
7   0.765  7.56  101    1.317  13.59 195    1.413  4.32 
8   0.466  9.05  102    2.844  43.80 196    1.814  5.8 
9   0.844  6.23  103    0.127  0.17  197    1.579  4.65 
10   0.577  11.13  104  0.652  15.66 198   0.035  1.61 
11 February 0.346 6.35 105    2.586 2.78  199    0.226 1.06 
12   1.378  4.28  106  2.372  9.30  200   0.328  1.94 
13   0.013  0.02  107  0.452  0.86  201   0.028  0.35 
14   1.642  1.42  108  3.640  50.43 202   0.359  0.49 
15   1.804  2.35  109  0.257  6.20  203   1.223  1.27 
16   1.602  2.08  110  0.816  7.04  204   1.568  5.03 
17   4.000  1.27  111  2.007  16.78 205   0.086  0.19 
18   3.789  1.27  112  3.094  2.81  206   0.612  0.45 
19   1.159  17.42  113  2.306  2.62  207   0.599  3.10 
20   1.323  1.02  114  1.596  2.88  208   0.479  6.73 
21   2.443  2.04  115  0.988  4.89  209   1.788  2.68 
22   4.359  1.96  116  0.563  3.53  210   3.781  3.35 
23   2.146  17.90  117  1.432  14.97 211   0.801  3.04 
24   1.160  18.50  118  1.978  23.16 212   1.949  0.84 
25   0.469  60.02  119  1.048  6.51  213   0.163  0.05 
26   0.823  5.23  120  0.102  26.59 214   0.784  0.63 
27   0.052  0.07  121  0.156  20.94 215   0.910  0.43 
28   1.231  7.24  122  1.931  19.02 216   0.152  0.36 
29   1.036  6.26  123  0.479  16.26 217   2.114  15.52 
30 March  0.823  14.92  124    0.301 50.89 218    1.031 12.83 
31   0.167  2.33  125  July  0.705  0.35  219   0.405  0.99 
32   0.323  7.81  126  0.714  0.42  220   0.118  0.34 
33   0.329  3.77  127  0.538  0.28  221   0.373  0.49 
34   0.132  0.82  128  0.627  0.39  222   1.482  0.47 
35   2.014  7.80  129  1.111  2.35  223   0.639  4.78 
36   0.516  2.40  130  0.941  1.38  224   0.808  9.01 
37   1.331  7.16  131  0.771  1.05  225   0.559  3.26 
38   2.159  22.95  132  0.673  0.52  226   0.755  1.35 
39   2.909  11.77  133  1.592  4.23  227   1.609  2.45 
40   0.981  2.62  134  0.351  2.85  228   1.748  1.20 
41   0.698  2.40  135  1.796  3.17  229   0.693  0.58 
42   0.803  0.48  136  1.300  1.27  230   0.831  0.71 
43   1.942  1.01  137  1.043  1.48  231   0.780  2.60 
44   0.105  0.91  138  0.638  3.00  232   0.196  0.38 
45   0.685  5.05  139  0.694  0.22  233   0.195  0.38 
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TABLE I. Continued 
Sample Month %  THC 
W 
index 
Sample Month %  THC
W 
index
Sample Month %  THC 
W 
index 
46   4.614  15.39  140  0.401  3.46  234   0.278  0.24 
47   0.352  1.12  141  0.744  3.24  235   0.208  0.45 
48   2.608  8.01  142  0.943  4.05  236   0.768  3.65 
49   0.665  3.05  143  1.490  3.05  237   0.028  0.04 
50 April  1.264  0.83  144    0.695  0.56  238    0.615  2.90 
51   0.458  0.25  145  0.732  0.83  239   0.063  0.17 
52   0.965  0.22  146  1.792  0.95  240   0.663  8.36 
53   0.536  0.16  147  0.889  0.58  241   0.689  6.89 
54   0.690  0.35  148  August  1.869  2.43  242   0.353  0.71 
55   0.391  0.18  149  1.746  8.74  243   0.836  1.43 
56   0.852  0.24  150  0.995  3.89  244  November  0.381  1.71 
57   0.301  5.25  151  1.727  3.20  245   1.249  0.80 
58   1.055  2.86  152  0.518  4.78  246   0.699  2.34 
59   1.608  3.45  153  0.080  9.29  247   1.425  5.52 
60   0.283  2.16  154  0.095  8.89  248   1.321  3.47 
61   0.696  8.46  155  0.129  3.92  249   0.504  4.35 
62   0.528  1.31  156  1.450  17.50 250   1.082  7.95 
63   0.301  31.10  157  1.737  0.70  251   0.765  7.00 
64   0.355  28.12  158  0.227  1.64  252   3.321  20.87 
65 May  2.211  5.26  159    0.943  3.16  253    0.757  6.58 
66   0.120  0.08  160  1.840  4.25  254   1.763  2.81 
67   0.817  6.66  161  1.591  4.10  255   1.326  2.55 
68   0.454  1.41  162  1.418  3.85  256   0.646  0.53 
69   1.426  16.99  163  0.699  0.28  257   0.447  3.42 
70   0.531  3.71  164  1.085  2.31  258   1.038  4.06 
71   0.416  4.47  165  0.717  0.35  259   0.420  2.50 
72   0.659  5.22  166  September 1.770 1.12  260    0.568  8.27 
73   0.612  5.11  167  0.906  4.24  261   2.191  1.86 
74   0.676  5.89  168  1.081  2.05  262   0.984  0.88 
75   0.622  7.53  169  0.962  13.11 263   0.605  0.54 
76   0.448  8.09  170  1.770  1.12  264   0.905  0.85 
77   0.695  8.04  171  0.900  4.54  265   1.012  10.42 
78   0.676  6.11  172  0.952  2.38  266   0.684  3.60 
79   0.919  5.00  173  0.925  3.25  267   3.911  6.21 
80   0.770  3.12  174  0.826  2.68  268  December  0.060  0.70 
81   0.380  3.15  175  0.835  9.35  269   0.486  4.65 
82 June  4.479  14.05  176    1.434  7.57  270    0.422  3.73 
83   1.662  26.76  177  0.818  9.44  271   2.144  0.34 
84   2.333  4.02  178  0.664  5.78  272   0.280  1.11 
85   1.003  3.47  179  0.130  2.29  273   1.705  1.90 
86   2.290  21.96  180  0.716  8.65  274   0.494  0.59 
87   0.734  1.85  181  0.175  0.23  275   1.923  1.44 
88   1.358  8.91  182  0.351  0.54  276   1.912  0.78 
89   0.310  4.23  183  October  0.190 0.28  277    1.045  1.36 
90   4.479  8.70  184  0.060  0.03  278   0.244  0.05 
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TABLE I. Continued 
Sample Month %  THC 
W 
index 
Sample Month %  THC
W 
index
Sample Month %  THC 
W 
index 
91   1.782  21.20  185  1.333  4.28  279   0.797  4.98 
92   0.688  11.43  186  1.446  1.37  280   2.282  2.46 
93   0.480  67.32  187  0.731  0.42  279   0.797  4.98 
94   1.609  1.93  188  0.712  0.48  280   2.282  2.46 
According to the present work, the Δ9-THC content varied from 0.013 to 
4.633 % and the Waller classification index from 0.02 to 67.32 % in the 280 can-
nabis samples seized during 2008 (Table I). The percent of drug, intermediate 
and fibre-type cannabis during 2008 was 77.5, 14.3 and 8.2, respectively. The 
most cannabis samples classified as a drug-type were seized in January and in 
May until September. During 2008, the monthly percent of drug-type cannabis 
varied from 46.7 to 100 %, of intermediate-type from 0 to 53.3 % and of fibre- 
-type from 0 to 24.6 % (Fig. 4). The percent of drug cannabis varied from 69.2 to 
100 % and that of textile cannabis from 0 to 24.6 % during 2008 (Fig. 5). The 
results showed that the Δ9-THC content in the illicitly circulated cannabis slight-
ly decreased from January until December 2008, as did the quality of the drug- 
-cannabis. The reasons for the quality variations could lie in the geographical ori-
gin of the cannabis plants, the conditions of plants storage, differing parts of the 
plants in the samples and the time elapsed between harvesting and chemical ana-
lysis. The highest Δ9-THC yield reached in the studied samples was 4.633 %. 
 
Fig. 4. Percent of drug, intermediate and fibre-type cannabis during twelve months in 2008. 
It is well known that there are wide variations in the relative amounts of 
cannabinoids in cannabis plants. This variation depends on numerous factors. 
The predominant factors are the genetic characteristics of the seed stock and the 
environment in which the plant is grown, such as: light, temperature, moisture 
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and oxygen.12,13 Some investigators concluded that the concentration of THC in 
marihuana is not dependent on the local growing conditions, but on the seed from 
which it is grown. It was also observed that THC will eventually decompose to 
CBN and that the original amount of THC present in marihuana can be computed 
by adding the amount of CBN to the THC present at the time of assay.14 
 
Fig. 5. Percent of drug and textile-type cannabis during twelve months in 2008. 
By assaying marihuana for its contents of THC, CBD and CBN, a great deal 
of information can be obtained regarding the potential source of the sample, its 
potency as a drug and the approximate time since it was first processed. It would 
also follow that if many confiscated samples had the same concentration of THC, 
CBD and CBN, it would be likely that they came from the same source, which 
could then be sought as a distribution point. 
Bearing in mind that seeds are freely transferred from one country to other, 
some investigators concluded that there is little valid basis for attempts to corre-
late the cannabinoid content with the country of origin and allocation of cannabis 
all over the world. However, Faubert Maunder15 is of opinion that the presence 
of CBD and its ratio to Δ9-THC is useful criterion for indicating the country of 
origin if the gross appearance of the sample is taken into account. Some inves-
tigators found that plants that are drug phenotype generally originate from count-
ries south of latitude 30 deg N. Plants that are fibre phenotype originate north of 
the same latitude.14 Cannabis plant material appears on the illicit market in diffe-
rent forms (buds, kilobricks, marihuana and sinsemilla) and that reflects to some 
extent on its country of origin. The concentration of CBN is a good indication of 
the age of samples as well as the storage conditions, indicating either old plant 
material or poor storage conditions. 
Diagnostic tools that allow independent descriptions of the sources of canna-
bis are essential for unravelling market dynamics.16 In this regard, Ritter17 called 
for pursuing multi-disciplinary approaches to understanding drug markets. A no-
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vel forensic approach to understanding the cannabis market is the employment of 
stable isotope analyses of seized cannabis. Stable isotope analysis has the poten-
tial to improve significantly the understanding of cannabis trafficking because 
stable isotopes function as natural recorders revealing aspects of the geographic 
origin and growth environment of a plant.18,19 
Based on the experience of some investigators, a concentration of THC in 
marihuana from 0.5 to 1.5 % can be considered as a “good” quality marihuana. If 
the concentration of THC is less than 0.5 %, the marihuana would be of poorer 
quality and cigarettes with a concentration of THC in excess of 1.5 % would be 
very good to excellent marihuana. Some attention must be given to the samples 
with THC content greater than 1.5 %. It is in this range that smoking marihuana 
can produce a diminution in the ability an individual to perform tasks requiring 
concentration, coordination and judgment.20 
CONCLUSIONS 
As cannabis is an illicit drug, it is only available to the public through illegal 
channels. Consequently, the chemical analysis of confiscated material is impor-
tant for the understanding of the health problems to the public associated with the 
use of any form of the drug. The analytical data generated could be employed to 
show trends in increasing or decreasing potency, to help identify the country of 
origin whenever possible and to provide information for policymaking decisions 
at the national and possibly international level. In addition, the analytical data 
should provide information to the scientific community in studying health prob-
lems associated with cannabis use. 
ИЗВОД 
САДРЖАЈ Δ
9-ТЕТРАХИДРОКАНАБИНОЛА У УЗОРЦИМА КАНАБИСА 
ЗАПЛЕЊЕНИМ У НОВОМ САДУ 2008. ГОДИНЕ 
МАЈА ЂУРЕНДИЋ-БРЕНЕСЕЛ, НИКША АЈДУКОВИЋ, КАТАРИНА ШТАЈНИЦ-РИСТИЋ, 
ВЛАДИМИР ПИЛИЈА и ИГОР ВЕСЕЛИНОВИЋ 
Institut za sudsku medicinu, Klini~ki centar Vojvodine, Hajduk Veqkova 7–9, 21000 Novi Sad 
Три основна канабиноида Δ
9-тетрахидроканабинол (Δ
9-THC), канабидиол (CBD) и ка-
набинол (CBN) су идентификована и квантификована на GCD (GC-EI) инструменту у 280 
узорака биљног материјала – канабиса, заплењених од стране органа истраге у Новом Саду 
2008 године. Заплењени узорци су достављени Институту за судску медицину Клиничког 
центра Војводине, како би се извршила форензичка хемијска анализа узорака. На основу 
садржаја канабиноида у узорцима извршена је класификација канабиса на три хемијска фе-
нотипа и диференцијација на канабис-дрога и канабис-текстилни тип, применом Waller-овог 
класификационог  индекса.  Наведена  диференцијација  има  изузетан  форензички  значај  у 
утврђивању  извесних  случајева  као  противзаконитих.  Експериментални  резултати у  овом 
раду указују да садржај Δ
9-ТHC-а у канабису на илегалном тржишту, благо опада у периоду 
од јануара до децембра 2008. године, а такође и квалитет канабиса типа дроге. Варијације у 
квалитету канабиса могу потицати од географског порекла биљки, услова њиховог чувања, 
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различитих уситњених делова биљке који се могу наћи у заплењеним узорцима или пак од 
временског периода између бербе и хемијске анализе узорака канабиса. 
(Примљено 19. октобра, ревидирано 15. децембра 2009) 
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